Question · Q3 2025
Matt Hettwer asked for comments on two items: the potential pace of execution against the $500 million share repurchase authorization and the expected cash proceeds from the pending divestiture deal with Bunge.
Answer
CFO Michael DeVeau stated that the share buyback program commenced on October 1st as part of a trading plan, targeting offsetting dilution (approximately $80 million annually, or $20 million for Q4). He noted flexibility to increase or decrease purchases based on intrinsic value and free cash flow. For the Bunge divestiture, he estimated gross proceeds of about $110 million and net cash proceeds of around $90 million after tax and deal fees.